Registry of Randomized Controlled Trials in Transplantation: January 1 to June 30, 2006
Aims and Quality of Trials Published Between January 1 and June 30, 2006
Aims and Quality of Trials That Were Identified After the Relevant Registry Was Published
Additional Information Regarding the Trials That Was Provided by the Authors
Can Old Be Too Old for Kidney Transplantation?
Cardiac Statins More Than Just Lipid Busters
Isolation of Large Numbers of Mesenchymal Stem Cells From the Washings of Bone Marrow Collection Bags: Characterization of Fresh Mesenchymal Stem Cells
Diabetic Complications Associated With New-Onset Diabetes Mellitus in Renal Transplant Recipients
Evaluation of Hepatocyte Growth Factor as a Sensitive Marker for Early Detection of Acute Renal Allograft Rejection
Maintenance Immunosuppression With Mycophenolate Mofetil and Corticosteroids in Pediatric Kidney Transplantation: Temporary Benefit but Not Without Risk
Gene-Expression Profiles and Age of Donor Kidney Biopsies Obtained Before Transplantation Distinguish Medium Term Graft Function
No Association of Factor V Leiden, Prothrombin G20210A, and MTHFR C677T Gene Polymorphisms With Kidney Allograft Survival: A Multicenter Study
The Functional, Metabolic, and Anabolic Responses to Exercise Training in Renal Transplant and Hemodialysis Patients
Renal Transplantation in Elderly Patients Older Than 70 Years of Age: Results From the Scientific Registry of Transplant Recipients
Transfer of Allograft Specific Tolerance Requires CD4+CD25+T Cells but Not Interleukin-4 or Transforming Growth Factor–β and Cannot Induce Tolerance to Linked Antigens
Successful Islet Transplantation to Two Recipients From a Single Donor by Targeting Proinflammatory Cytokines in Mice
Pitavastatin Suppresses Acute and Chronic Rejection in Murine Cardiac Allografts
Rapamycin Enhances the Number of Alloantigen-Induced Human CD103+CD8+ Regulatory T Cells In Vitro
Regulatory T-Cells in the Graft and the Risk of Acute Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation
Rapamycin Inhibits Proliferation of Epstein-Barr Virus–Positive B-cell Lymphomas Through Modulation of Cell-Cycle Protein Expression
Experimental and Clinical Significance of Antinuclear Antibodies in Liver Transplantation
Antibodies Against Glutathione S-Transferase T1 (GSTT1) in Patients With GSTT1 Null Genotype as Prognostic Marker: Long-Term Follow-Up After Liver Transplantation
Blood Concentration Curve of Cyclosporine: Impact of Itraconazole in Lung Transplant Recipients
Cold Heparinized Lactated Ringers With Procaine (HeLP) Preservation Fluid in 266 Living Donor Kidney Transplantations
Interventional Trials Involving Patients Cannot Be Performed Safely Without a Control Group Treated With the Standard of Care
Author's Reply
Race and Living Kidney Donors
Authors' Reply